Company: KVACU
Filing Date: 2025-12-22
Form Type: PRE 14A
Source: 0001213900-25-124633
Chunk: 43

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-12-22
Form: PRE 14A
Chunk 43
---
 his family
business, Lawman Group International, and served as the Owner and President of Lawman Sportswear Inc., where he repositioned the Lawman
brand in China and launched the Petrol denim collection in the U.S. Presently, he holds the position of Vice President at Lawman International
Limited, overseeing property management.

Mr.
Chu started his career at Booz-Allen & Hamilton, later holding positions at Merrill Lynch and Wit Soundview. He holds a B.A. in East
Asian Studies from Harvard University.

We
believe Mr. Chu is well-qualified to serve as a member of our board of directors given his experience, industry expertise, and network.

Professor YU, Albert Cheung-Hoi, Ph.D., J.P.

Prof.
Yu, one of our independent directors since October 2021, has over 30 years of academic, industrial and entrepreneurial experience in biotech.
Prof. Yu has been a professor at Peking University since December 2001, where he researches glia and neuro-diseases. He has also served
as founder, chairman and Chief Scientific Officer of pioneering molecular diagnostic company Hai Kang Life Corporation Ltd since May 1999.

Concurrently,
Prof. Yu serves roles in 22 companies and organizations, including RNA interference (RNAi) therapeutics biopharmaceutical company Sirnaomics
Ltd (independent non-executive director since July 2021), venture capital fund CR-CP Life Science Fund Management Limited (independent
director since May 2021), international biotech convention organizer BIOHK Limited (director since February 2019), the Biotech Advisory
panel of the Stock Exchange of Hong Kong Limited (HKEX) (panel member since April 2018), the Guangdong-Hong Kong-Macao Greater Bay Area
Biotechnology Alliance (GBABA) (director, founder and chairman since December 2017), the Glia and Neuro-diseases Committee of the Beijing
Society for Neuroscience (BJSN) (director since December 2017), nonprofit international scientific conferences organizer, Gordon Research
Conferences (member of the Board of Trustees since May 2016), the Asian Fund for Cancer Research Limited (director since July 2011), Hong
Kong Biotechnology Organization (HKBIO) (founder and chairman since September 2009), Hong Kong DNA Chips Ltd (director since April 2007),
and clinical diagnostic firm Hai Kang Life Corp. Ltd.’s subsidiary DNA-Tech Ltd